353 authorised products across national registers.
United Kingdom — VMD
Australia — APVMA PUBCRIS
Canada — Health Canada DPD
United States — DailyMed (NLM)
No residue limits (MRL) are recorded for this substance.
No antimicrobial-resistance surveillance is recorded for this substance.
Spontaneous adverse-event reports that name Milbemycin Oxime, by species — reported counts, not proven reactions.
Top reactions: Emesis (42,902) · Vomiting (38,995) · Lethargy (see also Central nervous system depression in 'Neurological') (21,869) · Lack of efficacy (endoparasite) - heartworm (14,074) · Lack of efficacy - NOS (13,033)
Top reactions: Lethargy (see also Central nervous system depression in 'Neurological') (123) · Vomiting (116) · Accidental exposure (106) · Lack of efficacy (ectoparasite) - ear mite (76) · Emesis (53)
Source: openFDA Animal & Veterinary adverse-event reports.
Reading about Milbemycin Oxime? Pet products get recalled all the time — get a free email when a new pet-relevant recall is published. Unsubscribe any time.
Opt-in only: we store your email, language, optional species filter and the page you signed up on, and send a welcome email with a one-click unsubscribe link. We never share your address.
